drugset / Trial / NCT03826498

Allogenic Cord Blood Transfusion in Patients With Cerebral Palsy

NCT03826498 ↗

Non-randomizedParallel-groupOpen-labelTreatment

Summary

Cerebral palsy is a disorder of movement and posture resulted from a non-progressive lesion or injury of the immature brain. It is a leading cause of childhood onset disability. Many experimental animal studies have revealed that umbilical cord blood is useful to repair neurological injury in brain. On the basis of many experimental studies, umbilical cord blood is suggested as a potential therapy for cerebral palsy.

Timeline

Start
2018-01-12
Primary completion
2024-01-26
Completion
2024-12-26

Drugs

EvaluationDrugModalityDoseRoute
Subject CB-MNC Cell therapy — Other

Indications